logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
D

Davide Rossini

Careggi University Hospital

42H指数
182论文数
5.6K被引数
收录论文 59
发表时间
logo
Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO帕尼单抗（panitumumab）再治疗随后使用瑞戈非尼（regorafenib）与相反顺序在RAS和 BRAF野生型循环肿瘤DNA的化学耐药性转移性结直肠癌患者中的比较：GONO进行的PARERE研究
errAnnals of Oncology
IF65.4
err2025-10-18
err0
errOAAI
errP. Ciracì; M.M. Germani; F. Pietrantonio; P. Manca; S. Lonardi; A. Busico; F. Bergamo; V. Burgio; F. Mannavola; S. Di Donato; E. Fenocchio; F. Palermo; I. Capone; M.C. De Grandis; N. Pella; M. Scartozzi; L. Antonuzzo; A. Passardi; M. Claravezza; L. Salvatore; S. Tamberi; G. Randon; E. Conca; V. Conca; C. Antoniotti; R. Moretto; G. Masi; L. Boni; D. Rossini; C. Cremolini
err分享
err收藏
Risk of disease progression in the first-line therapy of metastatic colorectal cancer to guide disease re-assessments - analysis of eleven trials by AIO and GONO转移性结直肠癌一线治疗中疾病进展的风险，以指导疾病再评估——AIO和GONO对11项试验的分析
errAnnals of Oncology
IF65.4
err2025-08-19
err0
errOAAI
errM.M. Germani; V. Heinemann; D. Rossini; L. Fischer von Weikersthal; F. Pietrantonio; K. Heinrich; A. Stahler; S. Lonardi; F. Kaiser; T. Decker; L. Salvatore; L. Weiss; F. Morano; M. Fuchs; F. Bergamo; C. Antoniotti; G. Masi; S. Stintzing; P. Frumento; C. Cremolini; D.P. Modest
err分享
err收藏
Quantum simulations of complex systems复杂系统的量子模拟
errRIVISTA DEL NUOVO CIMENTO
IF7.4
err2025-05-16
err0
errOAAI
errOliver Morsch; G. Massimo Palma; Davide Rossini
err分享
err收藏
Extractable energy from quantum superposition of current states从电流状态量子叠加中可提取的能量
errQUANTUM SCIENCE AND TECHNOLOGY
IF5
err2025-03-27
err0
errOAAI
errPerciavalle, Francesco; Rossini, Davide; Polo, Juan; Amico, Luigi
err分享
err收藏
Chaos and magic in the dissipative quantum kicked top
errQUANTUM
IF5.4
err2025-03-05
err0
errOAAI
errPassarelli, G.; Lucignano, P.; Rossini, D.; Russomanno, A.
err分享
err收藏
Quantum superpositions of current states in Rydberg-atom networks
errPHYSICAL REVIEW RESEARCH
IF4.2
err2024-10-09
err1
errOAAI
errPerciavalle, Francesco; Rossini, Davide; Polo, Juan; Morsch, Oliver; Amico, Luigi
err分享
err收藏
Interplay between short-range and critical long-range fluctuations in the out-of-equilibrium behavior of the particle density at quantum transitions
errPHYSICAL REVIEW B
IF3.7
err2024-07-08
err1
errOAAI
errRossini, Davide; Vicari, Ettore
err分享
err收藏
Many-body quantum heat engines based on free fermion systems
errPHYSICAL REVIEW B
IF3.7
err2024-06-20
err0
errOAAI
errArezzo, Vincenzo Roberto; Rossini, Davide; Piccitto, Giulia
err分享
err收藏
Clinical outcomes in pT4N0 colon cancer (CC) patients: Data from a large, multicenter, real-word cohort
errANNALS OF ONCOLOGY
IF65.4
err2024-06-01
err0
PREAI
errDapra, V.; Rossini, D.; Puccini, A.; Schietroma, F.; Cosmai, A.; Di Francesco, L.; Zoratto, F.; Costantini, M.; Formica, V.; Rofei, M.; Mauri, G.; Bonazzina, E. F.; Iaia, M.; Signorelli, C.; Antonuzzo, L.; Damonte, C.; Spinelli, A.; Tortora, G.; Santoro, A.; Salvatore, L.
err分享
err收藏
FOLFOXIRI/bevacizumab (bev) versus doublets/bev as initial therapy of unresectable liver-only (LL), right-sided and/or RAS or BRAF mutated (mut) metastatic colorectal cancer (mCRC): An individual patient data-based pooled analysis of randomized trialsFOLFOXIRI/贝伐单抗 (bev) 与双药/bev作为不可切除的肝脏 (LL)，右侧和/或RAS或BRAF突变 (mut) 转移性结直肠癌 (mCRC) 的初始治疗: 基于个体患者数据的随机试验汇总分析
errANNALS OF ONCOLOGY
IF65.4
err2024-06-01
err0
PREAI
errMarmorino, F.; Antoniotti, C.; Meinert, F. M.; Bergamo, F.; Tonini, G.; Rossini, D.; Borelli, B.; De Rosa, A.; Allegrini, G.; Stein, A.; Moretto, R.; Ronzoni, M.; Zaniboni, A.; Germani, M. M.; Sperotto, S.; Ongaro, E.; Ghelardi, F.; Masi, G.; Schmoll, H. J. E-V.; Cremolini, C.
err分享
err收藏
p16 immunohistochemical (IHC) expression (exp) predicts benefit from irinotecan in metastatic colorectal cancer (mCRC): A translational analysis of the TRIBE and TRIBE2 studies
errANNALS OF ONCOLOGY
IF65.4
err2024-06-01
err0
PREAI
errStudiale, V.; Germani, M. M.; Moretto, R.; Conca, V.; Signorini, F.; Proietti, A.; Giordano, M.; Rossini, D.; Taravella, A.; Murgioni, S.; Russo, A.; Passardi, A.; Latiano, T. P.; Zaniboni, A.; Aprile, G.; Di Paolo, G.; Pietrantonio, F.; Ugolini, C.; Cremolini, C.
err分享
err收藏
Entanglement transitions and quantum bifurcations under continuous long-range monitoring
errPHYSICAL REVIEW B
IF3.7
err2023-09-18
err11
errOAAI
errRussomanno, Angelo; Piccitto, Giulia; Rossini, Davide
err分享
err收藏
Logarithmic entanglement scaling in dissipative free-fermion systems
errPHYSICAL REVIEW B
IF3.7
err2022-12-23
err3
errOAAI
errD'Abbruzzo, Antonio; Alba, Vincenzo; Rossini, Davide
err分享
err收藏
Discrete Time-Crystalline Response Stabilized by Domain-Wall Confinement
errPHYSICAL REVIEW X
IF15.7
err2022-09-14
err19
errOAAI
errCollura, Mario; De Luca, Andrea; Rossini, Davide; Lerose, Alessio
err分享
err收藏
Primary tumor resection (PTR) in metastatic colorectal cancer (mCRC) patients (pts) treated with upfront chemotherapy (CT) plus bevacizumab (BEV): A pooled analysis of TRIBE and TRIBE2 studies
errANNALS OF ONCOLOGY
IF65.4
err2022-09-01
err0
PREAI
errFanotto, V.; Boccaccino, A.; Casagrande, M.; Bergamo, F.; Spagnoletti, A.; Santini, D.; Antoniotti, C.; Allegrini, G.; Daniel, F.; Nasca, V.; Rossini, D.; Zaniboni, A.; Borelli, B.; Carullo, M.; Conca, V.; Passardi, A.; Tamburini, E.; Masi, G.; Cremolini, C.; Pella, N.
err分享
err收藏
An immune-related gene expression profile predicts the efficacy of adding atezolizumab to first-line FOLFOXIRI/bevacizumab in metastatic colorectal cancer: A translational analysis of the phase II randomized AtezoTRIBE study
errANNALS OF ONCOLOGY
IF65.4
err2022-06-01
err0
errOAAI
errAntoniotti, C.; Boccaccino, A.; Seitz, R.; Giordano, M.; Rossini, D.; Ambrosini, M.; Salvatore, L.; McGregor, K.; Bergamo, F.; Conca, V.; Leonetti, S.; Provenzano, L.; Tamberi, S.; Ramundo, M.; Tortora, G.; Rasola, C.; Ross, D.; Passardi, A.; Nielsen, T.; Varga, M.; Cremolini, C.
err分享
err收藏
Modified FOLFOXIRI plus panitumumab (mFOLFOXIRI/PAN) versus mFOLFOX6/PAN as initial treatment of unresectable RAS/BRAF wild-type metastatic colorectal cancer (mCRC) patients: Results of the phase III randomized TRIPLETE study by GONO
errANNALS OF ONCOLOGY
IF65.4
err2022-06-01
err0
errOAAI
errRossini, D.; Antoniotti, C.; Lonardi, S.; Pietrantonio, F.; Marmorino, F.; Antonuzzo, L.; Boccaccino, A.; Randon, G.; Giommoni, E.; Pozzo, C.; Moretto, R.; De Grandis, M.; Viola, M.; Passardi, A.; Borelli, B.; Buonadonna, A.; Masi, G.; Formica, V.; Aprile, G.; Boni, L.; Cremolini, C.
err分享
err收藏
Entanglement transitions in the quantum Ising chain: A comparison between different unravelings of the same Lindbladian
errPHYSICAL REVIEW B
IF3.7
err2022-02-22
err42
errOAAI
errPiccitto, Giulia; Russomanno, Angelo; Rossini, Davide
err分享
err收藏
Coherent and dissipative dynamics at quantum phase transitions量子相变的相干和耗散动力学
errPHYSICS REPORTS-REVIEW SECTION OF PHYSICS LETTERS
IF29.5
err2021-11-01
err56
errOAAI
errRossini, Davide; Vicari, Ettore
err分享
err收藏
Topological signatures in a weakly dissipative Kitaev chain of finite length
errPHYSICAL REVIEW B
IF3.7
err2021-09-20
err6
errOAAI
errD'Abbruzzo, Antonio; Rossini, Davide
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
H
Hans‐Joachim Schmoll
H 指数: 98 · 论文数: 1.1K
G
Giampaolo Tortora
H 指数: 93 · 论文数: 1.2K
G
Giuseppe Tonini
H 指数: 85 · 论文数: 1.2K
D
Daniele Santini
H 指数: 85 · 论文数: 1.3K
S
Sara Lonardi
H 指数: 83 · 论文数: 1.2K
查看更多